Cannabis farms and facilities across Australia are actively contributing to long-term studies, trialling new cultivation techniques, and advocating for better, more sustainable practices across the board.
Our agricultural industry is already well-established for cannabis integration, thanks in part to the fact that Australian agribusinesses have invested in sustainable practices decades ahead of the curve.
Our arid climate and sensitivity to changes in climatic conditions was the driving force to this early adoption of sustainability values.
Similarly, we also boast a significantly larger percentage of under-utilised arable and non-arable land in regional areas when compared to other big agricultural sectors worldwide like the US and China.
As more cannabis farms and research facilities are setting up shop all over regional Australia, the sky’s the limit for Aussie growers looking to make their contribution to this rapidly scaling global market.
Developing New Cannabis Cultivars for Medicinal Purposes
With calls for more environmentally resilient crops, regional cannabis producers are actively involved in breeding programs to develop improved strains – and it all starts with developing the right weed seeds.
Developing cultivars with stable cannabinoid profiles, disease resistance, shorter growth cycles, and higher yields directly supports consistency and efficacy in medicinal use.
With this improved stability, Australia’s medicinal cannabis products can deliver more consistent effects.
This in turn, will make medical prescriptions easier to facilitate not only in Australia but worldwide.
Alongside this, research into cannabis cultivation is also allowing Australian growers to create medical-grade cannabis that delivers all the desired effects through balancing CBD (cannabidiol) content and the more intoxicating THC (tetrahydrocannabinol) content.
With careful phenotyping and selective breeding, growers are also isolating strains that are high in rare cannabinoids like CBG or THCV, which could have unique benefits for the treatment of inflammation, appetite regulation, and neurological conditions.
By curating effects and establishing greater control over the levels of intoxication in medicinal-grade cannabis cultivars, Australian growers can develop a product that allows for more sustainable medicinal use, allowing us to integrate this plant-based medicine into mainstream healthcare.
Supporting Clinical Trials for Medicinal Cannabis
More Australian cannabis facilities are joining forces with university and health organisations to conduct large-scale clinical trials on cannabis’s effectiveness in treating conditions such as chronic pain, anxiety, epilepsy and even PTSD.
Although medical cannabis is legal in Australia, doctors are cautious to prescribe it due to patchy research and a lack of standardised data.
With these clinical trials, however, sentiments surrounding plant-based medicine are starting to change.
For example, recent trials by Mater have started to show promising outcomes around the use of cannabinoids to manage symptoms in palliative care and treatment-resistant conditions.
Some growers are also collaborating closely with ethics committees and regulators to improve patient access to participation in these clinical trials, stating a high demand across patients in palliative care and across patient profiles that include diverse types of chronic conditions.
These studies are shaping public policy and building credibility in the medical community, both here in Australia as well as abroad.
Cultivating a Sustainable Industry from the Ground-Up
Industrial agriculture has always been resource-intensive – even for hydroponic facilities.
Indoor grow lights are energy guzzlers, and bad farming practices can contribute to water waste, nutrient runoff and mountains of needless emissions.
Thankfully, more Australian cannabis facilities are investing in clean energy solutions and greener growing technologies.
Some growers are employing solar-powered greenhouses, closed-loop water systems and organic growing media.
Others are using artificial intelligence and the latest in climate control tech to lower energy use without compromising on pharmaceutical standards.
Alongside developing cultivars for improved medicinal applications, Australian cannabis farmers are also creating more drought-tolerant and heat-resistant strains that allow for easier cultivation in arid regions across Australia.
These climate-optimised plants are already thriving across regional facilities, including Shepparton’s Cannatrek facility.
And with these innovations comes the potential for more cannabis agriculture investments across regional Australia, which will in turn, generate a large volume of new jobs in our national agricultural sector.
Raising the Bar on Product Quality & Consistency
Australia's stringent drug policies mean its domestic growers are already a step ahead when it comes to ensuring consistency in medicinal-grade cannabis, but many growers are going even further: using in-house laboratories, third-party testing and pharma-grade manufacturing processes to ensure every single product meets the mark.
It’s not just about cannabinoids, either.
From terpenes to flavonoids and moisture levels, every single variable is being monitored, recorded, and optimised by our future-oriented cannabis growers.
Some are even GMP (Good Manufacturing Practice) certified, which is the same standard used for producing mainstream pharmaceutical-grade products like over the counter medication.
Why does this matter for research?
Because it means clinical studies conducted with Australian-grown cannabis have tighter controls and better replicability.
This means the data from Australian studies will be more reliable, more respected, and more likely to be incorporated into future healthcare protocols around the world.
Recording the Unique Value of Australian Cannabis Research
Though Australia’s legalised medicinal cannabis market may be progressing with caution in parliament, our cannabis industry is definitely growing with purpose, precision, and a clear eye on the future.
From carefully selected cannabis cultivars to cutting-edge sustainability and next-gen growing methodologies, Aussie cannabis growers are setting a standard in future-ready hemp.
And with global demand for plant-based medicine continuing to rise, it’s fair to say that these foundational investments in cannabis will ensure Australia is well-positioned to be a key player in what’s already projected to be a highly lucrative global market.
4°C